Bazelet Group

What Bazelet Group does

Bazelet Group is an EU-GMP certified medical cannabis manufacturer founded in 2007 and headquartered in Or Akiva, Israel. The company processes cannabis from four of Israel's eight legal farms and reports serving approximately 9,000 patients per month. It operates the largest cannabis production site in the Middle East and positions itself as a formulation company rather than a commodity supplier, emphasizing batch-to-batch consistency and pharmaceutical-grade documentation. A second EU-GMP facility in Malta extends its reach into European and other regulated markets.

The company's core technology centers on precision terpene engineering and reproducible extraction/formulation methods developed over more than a decade under Chief Scientist Prof. Ari Eyal. The portfolio includes 60+ patent families and dozens of distinct terpene-enriched oil formulations developed for different patient populations, with clinical validation through randomized, double-blind, placebo-controlled trials at leading Israeli medical centers across indications including ADHD, autism spectrum disorder, and pain. Quality is enforced by ISO 17025-accredited in-house laboratories that release every batch of raw material and finished product. Bazelet holds EU-GMP, IMC-GMP, and ISO 17025 certifications.

Bazelet operates a B2B enterprise model serving four customer segments — distributors, importers, pharmacies, and pharma partners — across Europe and the Middle East. Revenue flows through two streams: branded formulation sales and CMO/white-label manufacturing services producing oils and flower to partner specifications. Pricing is not publicly disclosed and is handled through direct partnership engagement and custom quotes. The company is privately held, employs 51–100 people, and does not disclose revenue, funding history, or ownership structure in the available source material.

Name

Bazelet Group

Legal name

Bazelet Group

Website

https://bazelet-n.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

51–100 employees

Short description

Bazelet Group is an Israel-based, EU-GMP certified medical cannabis manufacturer that develops clinically-backed branded terpene-enriched formulations and offers CMO/white-label manufacturing services to distributors, importers, pharmacies, and pharma partners across European and Middle Eastern regulated markets.

Ownership category

akta.pro rank

Headquarters

HQ city

Or Akiva

HQ country

Israel

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Branded Formulation Sales: Sale of clinically-backed proprietary cannabis formulation oils developed in-house for different patient populations
2. CMO/White-Label Manufacturing: Contract manufacturing services for partners requiring white-label oils and flower produced to their own specifications under EU-GMP standards

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Bazelet Group is an EU-GMP certified developer and manufacturer of clinically-backed branded medical cannabis formulation oils and a CMO (Contract Manufacturing Organization) partner producing white-label oils and flower. The company operates two EU-GMP facilities—one in Or Akiva, Israel (the largest cannabis production site in the Middle East) and one in Malta—and serves distributors, importers, pharmacies, and pharma partners across regulated markets with batch-to-batch consistent, documented pharmaceutical-grade cannabis products.

Product overview

Bazelet Group is a formulation company, not a commodity supplier, offering two distinct product lines: (1) proprietary, clinically-backed branded cannabis formulations comprising dozens of terpene-enriched oil formulations developed for different patient populations, and (2) CMO white-label manufacturing services for oils and flower produced to partner specifications. Both product lines are manufactured under EU-GMP at their facilities in Or Akiva, Israel and Malta, with in-house quality laboratories releasing every batch.

Differentiator

Problem solved

Functional benefit

Products and services

• Terpene-Enriched Oil Formulations Proprietary branded cannabis formulation oils engineered to precise target specifications with defined terpene profiles, reproduced batch after batch with tolerances tighter than regulatory requirements. Produced under EU-GMP with full pharmaceutical-grade documentation, for distributors, importers, pharmacies, and pharma partners across regulated markets.
• White-Label Oils and Flower (CMO Manufacturing) Contract manufacturing organization (CMO) service producing white-label medical cannabis oils and flower to partner specifications under EU-GMP certification. Available to distributors, importers, pharmacies, and pharma partners seeking custom formulation development and scalable manufacturing.

Quantifiable outcome

• Formulation oils held to tighter tolerances than regulatory label requires
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• MediPharm Labs: Canadian licensed cannabis producer that built its core business around pharmaceutical-grade extraction and white-label/CMO services, directly comparable to Bazelet's extraction, formulation and white-label motion.
• Clever Leaves: Vertically integrated EU-GMP-certified medical cannabis cultivator and manufacturer operating from Colombia into European markets, comparable to Bazelet as an internationally focused EU-GMP producer serving regulated European distributors and pharmacies.
• Organigram Holdings: Canadian medical cannabis producer with formulated derivative products and EU-GMP-aligned operations targeting international medical markets, comparable to Bazelet's emphasis on engineered formulations and international supply.

Broad incumbents

• Tilray Brands: Large global cannabis operator with EU-GMP certified production in multiple countries and a portfolio of branded medical cannabis formulations, serving as a broad incumbent in the same EU-GMP medical cannabis category as Bazelet.
• Aurora Cannabis: Major global medical and consumer cannabis company with EU-GMP production and a medical-cannabis brand portfolio, overlapping with Bazelet's EU-GMP manufactured, branded formulation strategy.
• Canopy Growth: One of the largest global cannabis incumbents with EU medical cannabis brands and EU-GMP supply, representing a broader-scale competitor playing in the same regulated European distribution channels Bazelet targets.
• Cronos Group: Global cannabis operator with branded medical cannabis products and international distribution exposure, comparable as a broad incumbent in the EU/regulated medical cannabis formulations space.
• Jazz Pharmaceuticals: Owner of GW Pharmaceuticals and originator of cannabinoid-based prescription medicines (Sativex, Epidiolex); comparable as a pharma-grade cannabis medicine operator that validates pharmaceutical positioning of cannabis-derived therapeutics similar to Bazelet's clinical program.

Emerging players

• Tetra Bio-Pharma: Development-stage pharmaceutical cannabis company focused on clinically validated cannabinoid-derived drug candidates, overlapping with Bazelet's pharma-style clinical research strategy around indications such as pain and CNS disorders.
• Flora Growth: International cannabis operator with EU-GMP-aligned cultivation and formulation operations distributing into European markets, comparable as an emerging player attacking the same EU/regulated channel opportunity Bazelet addresses.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/bazelet-group/?viewAsMember=true

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bazelet Group